510(k) K212933
K212933 is an FDA 510(k) premarket notification submitted by Depuy Ireland UC for the device "INHANCETM Hybrid Anatomic Glenoid Implant". The FDA issued a decision of Substantially Equivalent on Jun 8, 2022. The device falls under product code MBF (Prosthesis, Shoulder, Semi-Constrained, Metal/Polymer, Uncemented), a Class II device regulated under 21 CFR 888.3670. Depuy Ireland UC has 49 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Jun 8, 2022
- Date Received
- Sep 15, 2021
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Prosthesis, Shoulder, Semi-Constrained, Metal/Polymer, Uncemented
- Device Class
- Class II
- Regulation Number
- 888.3670
- Review Panel
- OR
- Submission Type
- 510(k)
Need the full FDA record for Depuy Ireland UC? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.